Doxorubicin Recruiting Phase 2 Trials for Recurrent Ph-Like Acute Lymphoblastic Leukemia / CRLF2 Positive / B Acute Lymphoblastic Leukemia / Refractory Ph-Like Acute Lymphoblastic Leukemia / Leukemias Treatment